As of April 16, 2025, 2seventy bio (TSVT) has a market cap of $0.26 billion USD. According to our data, 2seventy bio is ranked No.6685 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.26 B |
71.51%
|
Dec 31, 2024 | $0.15 B |
-31.15%
|
Dec 29, 2023 | $0.22 B |
-54.43%
|
Dec 30, 2022 | $0.48 B |
-63.44%
|
Dec 31, 2021 | $1.32 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
Market Cap | = | TSVT Stock Price | * | TSVT Shares Outstanding |
= | $4.97 | * | 52.34 M | |
= | $0.26 B |